发布求助
文献互助 智能选刊 最新文献

B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE最新文献

筛选
英文 中文
ACE2 Treatment of Pulmonary Hypertension Requires the Mas1 Receptor, But Ang(1-7) Is Not the Ligand ACE2治疗肺动脉高压需要Mas1受体，但Ang(1-7)不是配体
B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3789
J. West, A. Hemnes, C. Moore, S. Gladson, S. Shay, A. Rathinasabapathy
{"title":"ACE2 Treatment of Pulmonary Hypertension Requires the Mas1 Receptor, But Ang(1-7) Is Not the Ligand","authors":"J. West, A. Hemnes, C. Moore, S. Gladson, S. Shay, A. Rathinasabapathy","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3789","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3789","url":null,"abstract":"","PeriodicalId":137806,"journal":{"name":"B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132502163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic Potential Of ACE2-Ang-(1-7)-MAS Axis on Right Ventricular Remodeling in Pulmonary Hypertension ACE2-Ang-(1-7)- mas轴对肺动脉高压右心室重构的治疗潜力
B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3779
Z. Dai
{"title":"Therapeutic Potential Of ACE2-Ang-(1-7)-MAS Axis on Right Ventricular Remodeling in Pulmonary Hypertension","authors":"Z. Dai","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3779","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3779","url":null,"abstract":"","PeriodicalId":137806,"journal":{"name":"B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130824218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Influence of Route and Formulation on the Pulmonary Pharmacokinetics of Imatinib in Nonclinical Species 伊马替尼给药途径及处方对非临床动物肺药代动力学的影响
B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3788
R. Niven, A. E. Cooper, H. Gillies, R. Wolff, B. Dake
{"title":"The Influence of Route and Formulation on the Pulmonary Pharmacokinetics of Imatinib in Nonclinical Species","authors":"R. Niven, A. E. Cooper, H. Gillies, R. Wolff, B. Dake","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3788","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3788","url":null,"abstract":"","PeriodicalId":137806,"journal":{"name":"B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE","volume":"142 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134065083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness and Safety of Riociguat as First-line or Combination Therapy in Pulmonary Arterial Hypertension (PAH): A Riociguat Users (ROAR) Registry Analysis 利奥西瓜特作为肺动脉高压(PAH)一线或联合治疗的有效性和安全性:利奥西瓜特用户(ROAR)注册分析
B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3785
R. White, A. U. Aranda, M. Chakinala, S. Mandras, J. McConnell, C. Miller, R. Sulica, D. Johnson, V. Carvajal, S. Bansilal, J. Kirkwold, N. Kim
{"title":"Effectiveness and Safety of Riociguat as First-line or Combination Therapy in Pulmonary Arterial Hypertension (PAH): A Riociguat Users (ROAR) Registry Analysis","authors":"R. White, A. U. Aranda, M. Chakinala, S. Mandras, J. McConnell, C. Miller, R. Sulica, D. Johnson, V. Carvajal, S. Bansilal, J. Kirkwold, N. Kim","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3785","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3785","url":null,"abstract":"","PeriodicalId":137806,"journal":{"name":"B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116619957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RKER-012, a Novel Activin Receptor Type IIB (ActRIIB) Ligand Trap, Inhibited Mediators of Dysregulated Vascular Remodeling in Pulmonary Endothelial and Smooth Muscle Cells RKER-012，一种新的激活素受体IIB (ActRIIB)配体陷阱，抑制肺内皮和平滑肌细胞血管重构失调的介质
B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3787
A. Gudelsky, E. Ledoux, C. Tseng, J. Seehra, J. Lachey
{"title":"RKER-012, a Novel Activin Receptor Type IIB (ActRIIB) Ligand Trap, Inhibited Mediators of Dysregulated Vascular Remodeling in Pulmonary Endothelial and Smooth Muscle Cells","authors":"A. Gudelsky, E. Ledoux, C. Tseng, J. Seehra, J. Lachey","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3787","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3787","url":null,"abstract":"","PeriodicalId":137806,"journal":{"name":"B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125948949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world Use of Upfront Combination Therapy in Pulmonary Arterial Hypertension (PAH) Patients 肺动脉高压(PAH)患者的前期联合治疗的实际应用
B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3784
C. Paoli, Wei Tang, S. Panjabi
{"title":"Real-world Use of Upfront Combination Therapy in Pulmonary Arterial Hypertension (PAH) Patients","authors":"C. Paoli, Wei Tang, S. Panjabi","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3784","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3784","url":null,"abstract":"","PeriodicalId":137806,"journal":{"name":"B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE","volume":"71 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123321046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study Design of the Decentralized EVOLVE Study Evaluating Real-world Use of Next Generation Infusion Pumps to Deliver Parenteral Treprostinil in Patients With Pulmonary Arterial Hypertension 分散式EVOLVE研究的研究设计，评估新一代输注泵在肺动脉高压患者中静脉注射treprostiil的实际应用
B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3777
M. Sketch, K. Maher, M. Broderick
{"title":"Study Design of the Decentralized EVOLVE Study Evaluating Real-world Use of Next Generation Infusion Pumps to Deliver Parenteral Treprostinil in Patients With Pulmonary Arterial Hypertension","authors":"M. Sketch, K. Maher, M. Broderick","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3777","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3777","url":null,"abstract":"","PeriodicalId":137806,"journal":{"name":"B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE","volume":"87 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133268385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhaled Milrinone in Pulmonary Hypertension: A Systematic Review and Meta-analysis 吸入米力农治疗肺动脉高压:系统回顾和荟萃分析
B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3776
K. El Gharib, F. Sakr, S. Asmar, C. Wei, M. Assaad, A. Kassem, N. Asogwa, J. Behgal, G. Khattar, S. Abu-Baker, H. El Hage
{"title":"Inhaled Milrinone in Pulmonary Hypertension: A Systematic Review and Meta-analysis","authors":"K. El Gharib, F. Sakr, S. Asmar, C. Wei, M. Assaad, A. Kassem, N. Asogwa, J. Behgal, G. Khattar, S. Abu-Baker, H. El Hage","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3776","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3776","url":null,"abstract":"","PeriodicalId":137806,"journal":{"name":"B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE","volume":"40 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133503910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信